Daiichi Sankyo Makes Organizational Changes

Daiichi Sankyo Company Limited announced a series of organizational and personnel changes, effective April 1, 2014.

Organizationally, within its Corporate Strategy Division, the current Corporate Strategy Department and the Global Brand Strategy Department under the Corporate Strategy Division will be integrated into a new Corporate Strategy Department. The move is part of a plan to enhance its global business strategy for the anticoagulant edoxaban. Also, reflecting the increased importance of its vaccine business, the Vaccine Business Intelligence Division will be made independent from Japan Company and placed as a business unit reporting directly to the CEO. The company also made changes to the sales department of Daiichi Sankyo Healthcare Co.

The company also made changes to its corporate officers as outlined here.

In order to effectively implement sales strategy by area, a sales department and branches consisting of the Chain Store Sales Department and seven branches will be reorganized into a new organization structure consisting of three sales departments with 12 branches. In order to effectively take sales measures planned by the head office in the Sales Division and ensure close cooperation between the head office and all sales departments, all groups under the current Sales Administration Department will be placed under the direct management of the head of the Sales Division and the department will be abolished. The name of the Sales Division will be changed into the Sales Administration Division.

Source: Daiichi Sankyo


Leave a Reply

Your email address will not be published. Required fields are marked *